Brexit – Impact of COVID-19

On 23 June 2016, the United Kingdom narrowly voted to leave the European Union, a decision which has impacted the lives of millions of people. Once the results of the historic vote were revealed, who would have predicted that the process to leave the European Union would take four and a half years.   While […]

COVID-19 – Impact on Hospital Patients

In response to the COVID-19 pandemic, and to prevent the NHS being overwhelmed due to a rapid increase of COVID-19 cases, the UK Government made a decision on 16th March 2020 to put the population of the UK into lockdown.   Before the pandemic began, the BBC reported that 1,600 patients were waiting for non-urgent […]

COVID-19 – Regulators respond – Australia, New Zealand Focus

Yesterday we looked at the response from the authorities in Middle East & Latin America  (COVID-19 – Regulators Respond – Middle East & Latin America Focus).  Today we’ll be focusing on Australia & New Zealand. Many aspects of our lives have been affected by the pandemic which has seen cases and deaths around the world. The pharmaceutical industry has by […]

COVID-19 – Regulators respond – Middle East & Latin America Focus

Yesterday we looked at the response from the authorities in India  (COVID-19 – Regulators Respond – India Focus).  Today we’ll be focusing on the Middle East and Latin America. Many aspects of our lives have been affected by the pandemic which has seen cases and deaths around the world. The pharmaceutical industry has by no means […]

COVID-19 – Regulators respond – India Focus

My last mini blog focused on the USA agency response (COVID-19 – Regulators Respond – USA Focus), today we’ll be looking at India. Many aspects of our lives have been affected by the pandemic which has seen cases and deaths around the world. The pharmaceutical industry has by no means escaped this impact. We have experienced […]

COVID-19 – Regulators respond – USA Focus

Last time we looked at the MHRA response (COVID-19 – Regulators Respond – UK Focus), today we shall focus on the USA. Many aspects of our lives have been affected by the pandemic which has seen cases and deaths around the world. The pharmaceutical industry has by no means escaped this impact. We have experienced an […]

COVID-19 – Regulators respond – UK Focus

Many aspects of our lives have been affected by the pandemic which has seen cases and deaths around the world. The pharmaceutical industry has by no means escaped this impact. We have experienced an increase in demand for products used to treat COVID-19 symptoms; the disruption of product supply; an impact on manufacturing, clinical trials […]

COVID-19 – Regulators respond – EU Focus

Today we’re looking at how regulatory authorities around the world are responding to the COVID-19 pandemic and, specifically, what flexibility they are offering to support the pharmaceutical industry. Many aspects of our lives have been affected by the pandemic which has seen cases and deaths around the world. The pharmaceutical industry has by no means […]